DE59108644D1 - Oligonucleotid-analoge mit terminalen 3'-3'-bzw. 5'-5'-Internucleotidverknüpfungen - Google Patents

Oligonucleotid-analoge mit terminalen 3'-3'-bzw. 5'-5'-Internucleotidverknüpfungen

Info

Publication number
DE59108644D1
DE59108644D1 DE59108644T DE59108644T DE59108644D1 DE 59108644 D1 DE59108644 D1 DE 59108644D1 DE 59108644 T DE59108644 T DE 59108644T DE 59108644 T DE59108644 T DE 59108644T DE 59108644 D1 DE59108644 D1 DE 59108644D1
Authority
DE
Germany
Prior art keywords
terminal
internucleotide linkages
oligonucleotide analogs
linkages
nuclease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE59108644T
Other languages
German (de)
English (en)
Inventor
Hannelore Roesch
Anja Froehlich
Jose Flavio Ramalho-Ortigao
Matthias Prof Dr Montenarh
Hartmut Prof Dr Seliger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Priority to DE59108644T priority Critical patent/DE59108644D1/de
Application granted granted Critical
Publication of DE59108644D1 publication Critical patent/DE59108644D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R15/00—Details of measuring arrangements of the types provided for in groups G01R17/00 - G01R29/00, G01R33/00 - G01R33/26 or G01R35/00
    • G01R15/14—Adaptations providing voltage or current isolation, e.g. for high-voltage or high-current networks
    • G01R15/18—Adaptations providing voltage or current isolation, e.g. for high-voltage or high-current networks using inductive devices, e.g. transformers
    • G01R15/186—Adaptations providing voltage or current isolation, e.g. for high-voltage or high-current networks using inductive devices, e.g. transformers using current transformers with a core consisting of two or more parts, e.g. clamp-on type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Power Engineering (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Peptides Or Proteins (AREA)
DE59108644T 1990-07-02 1991-06-26 Oligonucleotid-analoge mit terminalen 3'-3'-bzw. 5'-5'-Internucleotidverknüpfungen Expired - Lifetime DE59108644D1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE59108644T DE59108644D1 (de) 1990-07-02 1991-06-26 Oligonucleotid-analoge mit terminalen 3'-3'-bzw. 5'-5'-Internucleotidverknüpfungen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4021019 1990-07-02
DE59108644T DE59108644D1 (de) 1990-07-02 1991-06-26 Oligonucleotid-analoge mit terminalen 3'-3'-bzw. 5'-5'-Internucleotidverknüpfungen

Publications (1)

Publication Number Publication Date
DE59108644D1 true DE59108644D1 (de) 1997-05-07

Family

ID=6409497

Family Applications (1)

Application Number Title Priority Date Filing Date
DE59108644T Expired - Lifetime DE59108644D1 (de) 1990-07-02 1991-06-26 Oligonucleotid-analoge mit terminalen 3'-3'-bzw. 5'-5'-Internucleotidverknüpfungen

Country Status (22)

Country Link
US (1) US5750669A (enExample)
EP (1) EP0464638B1 (enExample)
JP (1) JP3186795B2 (enExample)
KR (1) KR100200400B1 (enExample)
AT (1) ATE151076T1 (enExample)
AU (1) AU647143B2 (enExample)
CA (1) CA2045891C (enExample)
CZ (1) CZ285408B6 (enExample)
DE (1) DE59108644D1 (enExample)
DK (1) DK0464638T3 (enExample)
ES (1) ES2099718T3 (enExample)
FI (1) FI104177B (enExample)
GR (1) GR3023432T3 (enExample)
HU (1) HU215147B (enExample)
IE (1) IE912309A1 (enExample)
IL (1) IL98672A (enExample)
NO (1) NO303018B1 (enExample)
NZ (1) NZ238769A (enExample)
PT (1) PT98169B (enExample)
SK (1) SK279544B6 (enExample)
TW (1) TW206232B (enExample)
ZA (1) ZA915056B (enExample)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223618A (en) * 1990-08-13 1993-06-29 Isis Pharmaceuticals, Inc. 4'-desmethyl nucleoside analog compounds
DK0593901T3 (da) * 1992-09-24 1997-10-27 Hoechst Ag Oligoribonucleotid- og ribozym-analoge med terminale 3-3- og 5-5-bindinger.
DE69407032T2 (de) * 1993-03-31 1998-07-02 Sanofi Sa Oligonucleotide mit amidverkettungen die phosphoesterverkettungen einsetzen
US6015886A (en) * 1993-05-24 2000-01-18 Chemgenes Corporation Oligonucleotide phosphate esters
US6605708B1 (en) * 1993-07-28 2003-08-12 Hybridon, Inc. Building blocks with carbamate internucleoside linkages and oligonucleotides derived therefrom
US5855911A (en) * 1995-08-29 1999-01-05 Board Of Regents, The University Of Texas System Liposomal phosphodiester, phosphorothioate, and P-ethoxy oligonucleotides
US9096636B2 (en) * 1996-06-06 2015-08-04 Isis Pharmaceuticals, Inc. Chimeric oligomeric compounds and their use in gene modulation
US7812149B2 (en) 1996-06-06 2010-10-12 Isis Pharmaceuticals, Inc. 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
US5898031A (en) 1996-06-06 1999-04-27 Isis Pharmaceuticals, Inc. Oligoribonucleotides for cleaving RNA
US7309692B1 (en) * 1996-07-08 2007-12-18 Board Of Regents, The University Of Texas System Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1
US6977244B2 (en) 1996-10-04 2005-12-20 Board Of Regents, The University Of Texas Systems Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
CN1060177C (zh) * 1997-06-28 2001-01-03 中国科学院上海生物化学研究所 3′－单磷酸化寡核苷酸
US7285288B1 (en) 1997-10-03 2007-10-23 Board Of Regents, The University Of Texas System Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
US7704962B1 (en) 1997-10-03 2010-04-27 Board Of Regents, The University Of Texas System Small oligonucleotides with anti-tumor activity
US6087112A (en) 1998-12-30 2000-07-11 Oligos Etc. Inc. Arrays with modified oligonucleotide and polynucleotide compositions
US20030180789A1 (en) * 1998-12-30 2003-09-25 Dale Roderic M.K. Arrays with modified oligonucleotide and polynucleotide compositions
DE19935756A1 (de) * 1999-07-27 2001-02-08 Mologen Forschungs Entwicklung Kovalent geschlossenes Nukleinsäuremolekül zur Immunstimulation
DE19935303A1 (de) 1999-07-28 2001-02-08 Aventis Pharma Gmbh Oligonukleotide zur Inhibierung der Expression von humanem eg5
US6271360B1 (en) * 1999-08-27 2001-08-07 Valigen (Us), Inc. Single-stranded oligodeoxynucleotide mutational vectors
EP1702983A3 (en) 2000-04-13 2007-01-10 Medical University of South Carolina Tissue-specific and pathogen-specific toxic agents, ribozymes, DNAzymes and antisense oligonucleotides and methods of use thereof
EP1289911A2 (en) * 2000-06-13 2003-03-12 Proligo LLC Universal solid supports for solid phase oligosynthesis and methods for their preparation and use
KR100894767B1 (ko) * 2000-09-26 2009-04-24 이데라 파마슈티칼즈, 인코포레이티드 화학적인 위치 변화에 의해 면역자극 올리고누클레오티드유사체의 면역자극 활성을 조절하는 방법
GB0114007D0 (en) * 2001-06-08 2001-08-01 Isis Innovation Oilgonucleotides
US7070933B2 (en) * 2001-09-28 2006-07-04 Gen-Probe Incorporated Inversion probes
WO2003061386A1 (en) * 2002-01-03 2003-07-31 Board Of Regents, The University Of Texas System Wt1 antisense oligos for the inhibition of breast cancer
EP1474432A1 (en) * 2002-02-04 2004-11-10 Biomira Inc. Immunostimulatory, covalently lipidated oligonucleotides
WO2004044133A2 (en) 2002-11-05 2004-05-27 Isis Pharmaceuticals, Inc. Modified oligonucleotides for use in rna interference
EP1560839A4 (en) 2002-11-05 2008-04-23 Isis Pharmaceuticals Inc CHIMERIC OLIGOMER COMPOUNDS AND THEIR USE IN GENE MODULATION
US8569474B2 (en) 2004-03-09 2013-10-29 Isis Pharmaceuticals, Inc. Double stranded constructs comprising one or more short strands hybridized to a longer strand
US8394947B2 (en) 2004-06-03 2013-03-12 Isis Pharmaceuticals, Inc. Positionally modified siRNA constructs
CA2568735A1 (en) * 2004-06-03 2005-12-22 Isis Pharmaceuticals, Inc. Double strand compositions comprising differentially modified strands for use in gene modulation
US7884086B2 (en) 2004-09-08 2011-02-08 Isis Pharmaceuticals, Inc. Conjugates for use in hepatocyte free uptake assays
CA2679750A1 (en) 2008-09-23 2010-03-23 Nexus Dx, Inc. Methods for detecting nucleic acids in a sample
EP2781523A1 (en) 2013-03-18 2014-09-24 Miltenyi Biotec GmbH Lipophilic oligonucleotide analogs
KR101323476B1 (ko) * 2013-06-12 2013-10-31 조선미 건물용 층간소음 방지재와 이를 이용한 층간소음 방지구조 및 그 시공 방법
LU92821B1 (en) 2015-09-09 2017-03-20 Mologen Ag Combination comprising immunostimulatory oligonucleotides
GB2542425A (en) 2015-09-21 2017-03-22 Mologen Ag Means for the treatment of HIV
CN109072223B (zh) * 2016-04-08 2022-10-21 川斯勒佰尔公司 多聚体编码核酸及其用途
CN111050806A (zh) 2017-06-02 2020-04-21 波涛生命科学有限公司 寡核苷酸组合物及其使用方法
CA3094598A1 (en) 2018-04-05 2019-10-10 Tsinghua University Methods of sequencing and producing nucleic acid sequences
EP3775203A4 (en) * 2018-04-12 2022-03-30 Wave Life Sciences Ltd. OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF
US12391942B2 (en) 2018-05-11 2025-08-19 Wave Life Sciences Ltd. Oligonucleotide compositions and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123610A (en) * 1977-03-09 1978-10-31 The United States Government Nucleic acid crosslinking agent and affinity inactivation of nucleic acids therewith
US4711955A (en) * 1981-04-17 1987-12-08 Yale University Modified nucleotides and methods of preparing and using same
FR2540122B1 (fr) * 1983-01-27 1985-11-29 Centre Nat Rech Scient Nouveaux composes comportant une sequence d'oligonucleotide liee a un agent d'intercalation, leur procede de synthese et leur application
DE3332068A1 (de) * 1983-09-06 1985-03-21 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von nukleosidalkyl-, aralkyl- und arylphosphoniten und -phosphonaten
US4795700A (en) * 1985-01-25 1989-01-03 California Institute Of Technology Nucleic acid probes and methods of using same
US5276019A (en) * 1987-03-25 1994-01-04 The United States Of America As Represented By The Department Of Health And Human Services Inhibitors for replication of retroviruses and for the expression of oncogene products
WO1989009221A1 (en) * 1988-03-25 1989-10-05 University Of Virginia Alumni Patents Foundation Oligonucleotide n-alkylphosphoramidates
AU5418290A (en) * 1989-03-31 1990-11-05 University Patents Inc. Polynucleotide phosphorodithioates as therapeutic agents for retroviral infections

Also Published As

Publication number Publication date
FI913169L (fi) 1992-01-03
HUT62010A (en) 1993-03-29
KR920002625A (ko) 1992-02-28
CA2045891A1 (en) 1992-01-03
NZ238769A (en) 1993-11-25
NO912585D0 (no) 1991-07-01
FI104177B1 (fi) 1999-11-30
US5750669A (en) 1998-05-12
DK0464638T3 (da) 1997-10-13
FI104177B (fi) 1999-11-30
TW206232B (enExample) 1993-05-21
CS201491A3 (en) 1992-01-15
HU912215D0 (en) 1991-12-30
CZ285408B6 (cs) 1999-08-11
FI913169A0 (fi) 1991-06-28
AU7947591A (en) 1992-01-02
PT98169B (pt) 1998-12-31
PT98169A (pt) 1993-09-30
NO303018B1 (no) 1998-05-18
AU647143B2 (en) 1994-03-17
ES2099718T3 (es) 1997-06-01
IE912309A1 (en) 1992-01-15
IL98672A (en) 1995-12-08
EP0464638B1 (de) 1997-04-02
EP0464638A2 (de) 1992-01-08
CA2045891C (en) 2003-07-22
ATE151076T1 (de) 1997-04-15
EP0464638A3 (en) 1992-09-02
IL98672A0 (en) 1992-07-15
JP3186795B2 (ja) 2001-07-11
SK279544B6 (sk) 1998-12-02
HU215147B (hu) 2000-03-28
NO912585L (no) 1992-01-03
KR100200400B1 (ko) 1999-06-15
ZA915056B (en) 1992-03-25
JPH05222088A (ja) 1993-08-31
GR3023432T3 (en) 1997-08-29

Similar Documents

Publication Publication Date Title
DE59108644D1 (de) Oligonucleotid-analoge mit terminalen 3'-3'-bzw. 5'-5'-Internucleotidverknüpfungen
FI893526A0 (fi) Material och metod foer oekning av nukleinsyrahybridisering.
DE3851079D1 (de) Vernetzbare Kunststoff-Zusammensetzung.
DE69004712D1 (de) Verfahren zur Herstellung von Polybutadien mit verbesserter Verarbeitkeit.
DE3889091D1 (de) Härtbare Zusammensetzung von Oxyalkylenpolymeren.
MA22905A1 (fr) Nouvelles sequences d'adn .
NO171981C (no) Alkynylaminonukleotider, fremgangsmaate for fremstilling derav, 7-jodnukleotider, merkede alkynyl-aminonukleotider samt fremgangsmaate for fremstilling av 7-(3-amino-1-propynyl)-2',3'-dideoxyguanosin-5'-trifosfat
DE3889393D1 (de) Verfahren zur Herstellung von 2,2,6,6-Tetramethyl-4-piperidylaminen.
ATE58529T1 (de) Verfahren zur herstellung von 2,2,6,6,-tetraalkyl-4-piperidylamine.
ATE60583T1 (de) Verfahren zur herstellung von 2,2,6,6-tetraalkyl- 4-piperidylaminen.
EP0354185A3 (en) Piperidine-triazine compounds for use as stabilizers for organic materials
IT1226123B (it) Turbopompa molecolare.
GR3004988T3 (enExample)
FI881526L (fi) Tvaerbundbar silylpolymerkomposition.
FR2674253B1 (fr) Composition lyophilisee pour la multiplication de sequences d'acides nucleiques.
IT1197853B (it) Composti politriazinici contenenti gruppi piperidinilammidinici e loro impiego come stabilizzanti per polimeri
WO1993013204A3 (de) Mittel zur stimulierung der teilungsaktivität tierischer zellen
DE69126610D1 (de) Darstellung von 3,4,6-trifluorophthalsäure
DE3869232D1 (de) Abkoemmlinge von bornan-3-spiro-l'-cyclopentan und diese enthaltende riechstoffzusammensetzungen.
Gharavi Molecular cloning of the human lipoxygenase gene
DE69011293D1 (de) Verfahren zur Herstellung von 4,4'-Dihydroxybiphenyl.
DE3788618D1 (de) Verfahren zur Herstellung von Thiazolo-(2,3-b)-chinazolonen.
ATE56913T1 (de) Herstellung von hohlen kunststoffartikeln.
ATE68122T1 (de) Herstellung von hohlen kunststoffartikeln.
NO884264L (no) 3'-azido-2',3'-dideoksyuridin-anti-retrovirus-blanding.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: AVENTIS PHARMA DEUTSCHLAND GMBH, 65929 FRANKFURT,

8327 Change in the person/name/address of the patent owner

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH, 65929 FRANKFURT,